Hosted on MSN1mon
Medifast (NYSE:MED) Surprises With Q4 Sales But Quarterly Revenue Guidance Significantly Misses ExpectationsKnown for its Optavia program that combines portion-controlled meal replacements with coaching, Medifast (NYSE:MED) has a broad product portfolio of bars, snacks, drinks, and desserts for those ...
Hosted on MSN1mon
Medifast outlines 2025 priorities with plans for $15M-$20M cost savings and new product expansionsThe company noted that clinical studies and product development efforts could impact near-term financials but are critical for long-term growth. Medifast is navigating significant challenges in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results